Beijing
China
Academy of Military Medical Sciences - Institute of Biotechnology
Heterologous boost, aerosolized adenovirus type-5 vector-based COVID-19 vaccine, safety, immunogenicity, inactivated COVID-19 vaccine, clinical trial
COVID-19 vaccines, inhaled vaccines, immunogenicity, SARS-CoV-2, Ad5-CoV, aerosol inhalation, booster
Safety, Immunogenicity, Long-term efficacy, Aerosolized Ad5-nCoV, Booster
COVID-19 vaccine, mucosal vaccine, children, adolescents, clinical trial